Company
Board Member
2025-05-20–present
Board Member
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
The company reported in an 8-K filed July 16, 2026 that Tamar Thompson resigned as director, effective July 15, 2026. The company reported in an 8-K filed July 8, 2026 that Tamar Thompson resigned as member of the board of directors of the Company and any committee thereof. The company reported in an 8-K filed May 23, 2025 that Tamar Thompson was appointed Director, effective May 20, 2025. Equibles holds 6 filed executive changes naming Tamar Thompson; each is listed under recent activity with its source filing.
“as of the Effective Time, each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) resigned and ceased to be directors of the board of directors of the Company and members of any committee thereof, as applicable.”
“each of the directors of the Company (Patrick J. McEnany; Richard J. Daly; Daniel J. Curran, M.D.; Donald A. Denkhaus; Molly Harper; Tamar Thompson; and David S. Tierney, M.D.) has indicated their intention to resign as a member of the board of directors of the Company and any committee thereof, as applicable, conditioned upon and effective as of the effective time of the Merger.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
Organization not stated
Board Member
SEC 8-K
2025-05-20–present
Organization not stated
Board Member
Proxy statement
Start not stated–2026-07-08
Organization not stated
Board Member
Proxy statement
Start not stated–2026-07-15
Recorded roles and call appearances connecting this person to public companies.
Company
Board Member
2025-05-20–present
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.